CXCL8 and ovarian cancer: Lokshin AE et al. [70] found that serum IL-8 and anti-IL-8 antibody levels were elevated in ovarian cancer patients compared to healthy controls, and that combining IL-8 and anti-IL-8 IgG with CA125 resulted in increased classification power compared to each marker analyzed separately.